Blog

Elotuzumab plus stem cell transplant shows promise for multiple myeloma – Healio

Elotuzumab plus stem cell transplant shows promise for multiple myeloma
Healio
SALT LAKE CITY — The addition of elotuzumab and autologous peripheral blood mononuclear cell reconstitution to autologous hematopoietic stem cell transplantation plus lenalidomide maintenance appeared effective with a manageable safety profile

2018-02-22 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.